Free provider profile
BENJAMIN YUDKOFF, MD
NPI 1962727966
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2022-08-10.
53 LANGLEY RD STE 250, NEWTON, MA, 02459
617-863-8810
Single practice location
Enumerated 2010-04-01
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 4 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
222
Medicare patients
17
Part D drug cost
$113,694
Brand-name share
39.2%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 71 | $83,699 |
| Gabapentin (Gabapentin) | 14 | $124 |
| Lorazepam (Lorazepam) | 11 | $75 |
| Alprazolam (Alprazolam) | 13 | $43 |
| Escitalopram Oxalate (Escitalopram Oxalate) | 13 | $28 |
| Clonazepam (Clonazepam) | 16 | $11 |
| Zolpidem Tartrate (Zolpidem Tartrate) | 13 | $10 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024228 sessions · 15 patients · $257,666
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.